SIREN : 393189113
IMMOXINE is a French company founded 32 years ago, specialized in the sector Activités des marchands de biens immobiliers. Based in DIJON (21000), this company of category PME shows in 2016 a revenue of 2.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | N/C | N/C | 2 656 493 € |
| Net income | 218 865 € | 936 279 € | 1 543 882 € | 1 164 585 € | 362 010 € | 494 569 € | 283 950 € | 263 106 € |
| EBITDA | N/C | N/C | N/C | N/C | N/C | N/C | N/C | 874 718 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | N/C | N/C | 9.9% |
In 2024, IMMOXINE generates positive net income of 219 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 263 k€ -> 219 k€.
218 865 €
The debt ratio (= Financial debt / Equity x 100) stands at 162%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.
161.763%
36.903%
63.6%
In 2024, the debt ratio of IMMOXINE (161.76) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of IMMOXINE (36.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
The liquidity ratio (= Current assets / Current liabilities) stands at 3321.22. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
3321.224
In 2024, the liquidity ratio of IMMOXINE (3321.22) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Indicative estimate only : the number of comparable transactions in this sector is limited (22 transactions). This range of 942 778€ to 4 276 241€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 22 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare IMMOXINE with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des marchands de biens immobiliers
The revenue of IMMOXINE in 2016 is 2.7 M€.
Yes, IMMOXINE generated a net profit of 219 k€ in 2024.
The headquarters of IMMOXINE is located in DIJON (21000), in the department Cote-d'Or.
The tax return of IMMOXINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
IMMOXINE operates in the sector Activités des marchands de biens immobiliers (NAF code 68.10Z). See the 'Sector positioning' section above to compare the company with its competitors.